Contingencies (Details)			6 Months Ended				6 Months Ended		6 Months Ended					6 Months Ended
	Jun. 30, 2011 USD ($)	Dec. 31, 2010 USD ($)	Jun. 30, 2011 Lorazepam and Clorazepate [Member] USD ($)	Jan. 18, 2011 Lorazepam and Clorazepate [Member] USD ($)	Feb. 06, 2008 Lorazepam and Clorazepate [Member] USD ($)	Jun. 01, 2005 Lorazepam and Clorazepate [Member] USD ($)	Jun. 30, 2011 Pricing and Medicaid Litigation [Member] USD ($)	Dec. 31, 2010 Pricing and Medicaid Litigation [Member] USD ($)	Jun. 30, 2011 Product Liabilities [Member] USD ($)	Dec. 31, 2010 Product Liabilities [Member] USD ($)	Sep. 30, 2010 Dey Business [Member] USD ($)	Apr. 08, 2011 Digitek Recall [Member]	Mar. 31, 2011 Digitek Recall [Member]	Jun. 30, 2011 EU Commission Proceedings [Member]	Jun. 30, 2011 Other Litigation [Member] USD ($)	Jun. 30, 2011 Other Litigation [Member] EUR (€)
Accrued amount for settlement by Mylan						$ 12,000,000	$ 127,000,000	$ 157,000,000		$ 41,000,000
Judgment amount					69,000,000
Compensation damages in original verdict					11,000,000
Compensatory damages in original verdict plus punitive damages					58,000,000
Surety bond underwritten by third party insurance company				74,500,000
Cash deposit as pledge	24,151,000	23,972,000		15,000,000
Irrevocable letter of credit				34,500,000
Settlement payments							30,000,000		15,000,000
Other current liabilities	956,284,000	1,057,573,000									127,000,000
Number of plaintiffs to opt out of settlement													15
Number of cases pending												1,000
Number of companies involved in inquiry														100
Damages sought			$ 8,000,000												$ 24,000,000	€ 17,000,000